| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022853 |
| Receipt No. | R000026057 |
| Official scientific title of the study | Endometriosis Promotion Project |
| Date of disclosure of the study information | 2016/09/01 |
| Last modified on | 2016/06/23 (Ver. 1) |
| Basic information | |||
| Official scientific title of the study | Endometriosis Promotion Project | ||
| Title of the study (Brief title) | Endometriosis Promotion Project | ||
| Region |
|
||
| Condition | ||
| Condition | endometriosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the pattern of cyclic or acyclic pain manifestation and their personal/social impact among teenage girls in some defined population in Kyoto and Thailand under the close supervision and guidance of Kyoto Prefectural Medical University in Kyoto, Japan and Mahidol University in Bangkok, Thailand. |
| Basic objectives2 | Others |
| Basic objectives -Others | To compare the difference of high risked patients with endometriosis between Japan and Thailand. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The end point of this epidemiological study is to early identify and manage teenage girls with adolescent endometriosis. |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Healthy women | |||
| Key exclusion criteria | none | |||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Khaleque Khan |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Obstetrics and Gynecology |
| Address | 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan |
| TEL | 075-251-5560 |
| nemokhan@koto.kpu-m.ac.jp | |
| Public contact | |
| Name of contact person | Khaleque Khan |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Obstetrics and Gynecology |
| Address | 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan |
| TEL | 075-251-5560 |
| Homepage URL | |
| nemokhan@koto.kpu-m.ac.jp | |
| Sponsor | |
| Institute | Kyoto Prefectural University of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kyoto Prefectural University of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | under consideration byIRB |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026057 |